Market Place
Sourcing Support
Actavis`s Generics Methylnaltrexone Br. Receives Approval in US
26 Aug 2024 //
FDA
Salix Announces a Phase 2 Investigator-Initiated Study of RELISTOR(R)
06 Mar 2024 //
ACCESSWIRE
Salix Will Present XIFAXAN(R, TRULANCE and RELISTOR Data at Scientific Meeting
24 Oct 2022 //
ACCESSWIRE
New Data on Cost Impact of Treating OIC with FDA-Approved Medications
24 Mar 2022 //
PRNEWSWIRE
Aegerion`s Biologic Myalept (Metreleptin) Receives Approval in the U.S.
28 Feb 2022 //
FDA
Salix Will Share RELISTOR® (Methylnaltrexone Bromide) Data At PAINWeek 2021
02 Sep 2021 //
PRNEWSWIRE
Salix Will Share RELISTOR® (Methylnaltrexone Bromide) Data Analysis at the 2021
03 Jun 2021 //
YAHOO
Salix To Highlight New Data Across Its Portfolio Products At Digestive Disease
30 Apr 2020 //
PRNEWSWIRE
Court upholds validity of patent protecting Relistor tablets
19 Jul 2019 //
THE PHARMALETTER
Salix Announces 2 Methylnaltrexone Poster for Opioid-Induced Constipation
13 Mar 2019 //
PR NEWSWRE
Aegerion`s Metreleptin Receives Supplemental Approval in US
21 Dec 2018 //
FDA
Myalepta receives EU marketing nod to treat generalized & partial lipodystrophy
02 Aug 2018 //
PHARMABIZ
Aegerion’s Myalepta Approved in Europe for Pts with Lipodystrophy
31 Jul 2018 //
BUSINESSWIRE
Summary Judgment Granted Upholding Formulation Patent Protecting RELISTOR®
02 May 2018 //
PR NEWSWIRE
Mylan Labs Generic Methylnaltrexone Bromide Receives Approval In US
06 May 2017 //
FDA
Valeant touts Salix salesforce scale-up amid rumors of mass rep exit
27 Feb 2017 //
FIERCE PHARMA
Purdue inks Shionogi collab on constipation med as it awaits FDA approval
19 Dec 2016 //
FIERCE BIOTECH
How much can a new EVP help Valeant`s badly battered derm unit?
14 Dec 2016 //
FIERCE PHARMA
Valeant looks to revive Xifaxan with primary care sales effort. Will it work?
02 Dec 2016 //
FIERCE PHARMA
Valeant Said to Keep Salix After Takeda Deal Falls Apart
01 Dec 2016 //
BLOOMBERG
Valeant Announces Initiation Of A Primary Care Sales For Xifaxan & Relistor
29 Nov 2016 //
PR NEWSWIRE
Valeant And Progenics Announce The U.S. Commercial Launch
06 Sep 2016 //
PR NEWSWIRE
Valeant Gets FDA OK for Anticonstipation Tablets Developed by Progenics
19 Jul 2016 //
WALL STREET JOURNAL
Sobi gains commercial rights from Pharma Swiss
07 Jan 2016 //
NORDIC LIFE SCIENCE
Valeant And Progenics Announce FDA Acceptance Of NDA Submission For Oral RELISTOR®
08 Sep 2015 //
PR NEWS WIRE
Valeant, Progenics file Relistor pill in the US
24 Jun 2015 //
PHARMA TIMES
Copyright © 2024 LePro PharmaCompass OPC Private Limited, All rights reserved.